These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37308794)

  • 1. A new targeted therapy for low-grade glioma.
    O'Leary K
    Nat Med; 2023 Jun; ():. PubMed ID: 37308794
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular markers and targeted therapy in pediatric low-grade glioma.
    de Blank P; Fouladi M; Huse JT
    J Neurooncol; 2020 Oct; 150(1):5-15. PubMed ID: 32399739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of emerging therapy in the management of patients with diffuse low grade glioma.
    Sloan AE; Okada H; Ryken TC; Kalkanis SN; Olson JJ
    J Neurooncol; 2015 Dec; 125(3):631-5. PubMed ID: 26530260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review.
    Thomas DL
    Chin Clin Oncol; 2023 Feb; 12(1):7. PubMed ID: 36922356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
    Hargrave D
    Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
    Chen R; Cohen AL; Colman H
    Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Genetics and Targeted Therapies for Paediatric High-grade Glioma.
    Rallis KS; George AM; Wozniak AM; Bigogno CM; Chow B; Hanrahan JG; Sideris M
    Cancer Genomics Proteomics; 2022; 19(4):390-414. PubMed ID: 35732328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era.
    Manoharan N; Liu KX; Mueller S; Haas-Kogan DA; Bandopadhayay P
    Neoplasia; 2023 Feb; 36():100857. PubMed ID: 36566593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology.
    Linzey JR; Marini BL; Pasternak A; Smith C; Miklja Z; Zhao L; Kumar-Sinha C; Paul A; Harris N; Robertson PL; Hoffman LM; Chinnaiyan A; Mody R; Koschmann C
    J Neurooncol; 2018 Mar; 137(1):155-169. PubMed ID: 29235051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigational Microbiological Therapy for Glioma.
    Wang J; Liu Y; Zhang A; Yu W; Lei Q; Xiao B; Luo Z
    Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging targeted therapies for glioma.
    Miller JJ; Wen PY
    Expert Opin Emerg Drugs; 2016 Dec; 21(4):441-452. PubMed ID: 27809598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of targeted therapy combined with radiotherapy and temozolomide-based chemotherapy in the treatment of glioma: A systemic review and meta-analysis of phase II/III randomized controlled trials.
    Ma Y; Wang Y; Nie C; Lin Y
    Front Oncol; 2023; 13():1082539. PubMed ID: 36776303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
    Plant-Fox AS; O'Halloran K; Goldman S
    Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early experience with targeted therapy as a first-line adjuvant treatment for pediatric low-grade glioma.
    Leclair NK; Lambert W; Roche K; Gillan E; Gell JJ; Lau CC; Wrubel G; Knopf J; Amin S; Anderson M; Martin JE; Bookland MJ; Hersh DS
    Neurosurg Focus; 2022 Dec; 53(6):E15. PubMed ID: 36455272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of pediatric low-grade glioma.
    de Blank P; Bandopadhayay P; Haas-Kogan D; Fouladi M; Fangusaro J
    Curr Opin Pediatr; 2019 Feb; 31(1):21-27. PubMed ID: 30531227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and low-grade glioma: the emergence of genetic information.
    Claus EB; Walsh KM; Wiencke JK; Molinaro AM; Wiemels JL; Schildkraut JM; Bondy ML; Berger M; Jenkins R; Wrensch M
    Neurosurg Focus; 2015 Jan; 38(1):E6. PubMed ID: 25552286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma.
    Rosenberg T; Yeo KK; Mauguen A; Alexandrescu S; Prabhu SP; Tsai JW; Malinowski S; Joshirao M; Parikh K; Farouk Sait S; Rosenblum MK; Benhamida JK; Michaiel G; Tran HN; Dahiya S; Kachurak K; Friedman GK; Krystal JI; Huang MA; Margol AS; Wright KD; Aguilera D; MacDonald TJ; Chi SN; Karajannis MA
    Neuro Oncol; 2022 Nov; 24(11):1964-1975. PubMed ID: 35397478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization of Diagnostic and Therapeutic Targets in Glioma With Molecular Imaging.
    Li D; Patel CB; Xu G; Iagaru A; Zhu Z; Zhang L; Cheng Z
    Front Immunol; 2020; 11():592389. PubMed ID: 33193439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic Analysis of Glioma Based on IDH Status Identifies ACAA2 as a Prognostic Factor in Lower Grade Glioma.
    Wu C; Song H; Fu X; Li S; Jiang T
    Biomed Res Int; 2020; 2020():1086792. PubMed ID: 32280672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.